SML3405
NVP-LDZ982
≥98% (HPLC)
别名:
LDZ-982, LDZ 982, LDZ982, Methyl 5-[1-(3-chlorophenyl)-5-(trifluoromethyl)-1H-pyrazol-4-yl]-3-(2,6-dichlorophenyl)isoxazole-4-carboxylate, NITD 982, NITD-982, NITD982
assay
≥98% (HPLC)
form
powder
color
, Light yellow to orange
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
Quality Level
Biochem/physiol Actions
Dihydroorotate dehydrogenase (DHODH) inhibitor with broad-spectrum antiviral activity against Dengue, HCV, HIV, Influenza, RSV, and Yellow fever.
NVP-LDZ982 (NITD-982) is a dihydroorotate dehydrogenase (DHODH) inhibitor (Kd = 27 nM) with broad-spectrum antiviral activity by targeting host cell de novo pyrimidine biosynthesis pathway. NITD-982 inhibits various viral replications in cultues, including Dengue (DENV EC50 = 5-2.6 nM; A549), hepatitis C virus (HCV EC50 = 7-12.6 nM; Huh-7), HIV (MDR769 EC50 = 0.97 nM; PBMC), Influenza (EC50 = 32 nM/H1N1, 117 nM/B, 217 nM/H1N3; MDCK), respiratory syncytial virus (RSV EC50 = 7-9 nM; Hep-2), and Yellow fever (strain 17D EC50 = 8.2 nM; A549).
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Inhibition of dengue virus through suppression of host pyrimidine biosynthesis
Journal of Virology, 85(13), 6548-6556 (2011)
Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV)
Proceedings of the National Academy of Sciences of the USA, 108(17), 6739-6744 (2011)
Kim Long Yeo et al.
Antimicrobial agents and chemotherapy, 59(4), 2086-2093 (2015-01-28)
Dengue virus (DENV) is the most prevalent mosquito-borne viral pathogen in humans. Currently, there is no clinically approved vaccine or antiviral for DENV. Combination therapy is a common practice in antiviral treatment and a potential approach to search for new
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持